PT-141, also called bremelanotide, is a prescription peptide that acts on melanocortin receptors in the brain, pathways involved in sexual desire and arousal. You can get it prescribed online: you complete a secure health questionnaire, a state-licensed provider reviews your heart health and medicines, and, if PT-141 is appropriate for you, a licensed pharmacy prepares a compounded injection or nasal spray and ships it to you.
The question people actually type is "where can I get PT-141 prescribed by a licensed doctor?" This guide answers it: what PT-141 is, who it's for and what "off-label" means here, how the online process works at CAPO Health, the safety points that matter most, and how to check any prescriber yourself. It's general information, not medical advice: the decision belongs to a licensed provider.
Key takeaways
- PT-141 (bremelanotide) works in the brain, on melanocortin receptors. It isn't a blood-flow medicine like tadalafil.
- The bremelanotide medicine the FDA has approved is labeled for one group: premenopausal women with a specific kind of low sexual desire. Other uses are off-label.
- Compounded PT-141 is not FDA-approved. A licensed provider decides whether it's safe and appropriate for you.
- Blood pressure matters: PT-141 can briefly raise blood pressure and lower heart rate, so heart history comes first.
- You can look up any prescriber's NPI and check the pharmacy before you start.
What is PT-141?
PT-141 is the development name of bremelanotide, a peptide in the class of medications called melanocortin receptor agonists. It activates melanocortin receptors in the brain, which are involved in sexual desire and arousal.
MedlinePlus, the National Library of Medicine's consumer drug guide, describes bremelanotide injection as working by activating certain natural substances in the brain. That makes it different from the medicines most people know for sexual health: tadalafil, for example, works by increasing blood flow to the penis during sexual stimulation. PT-141 acts on desire and arousal pathways; PDE5 inhibitors act on blood flow. They're different tools for different problems, and a provider can help you sort out which question you're really asking.
The MedlinePlus page describes the bremelanotide medicine the FDA has approved, a prefilled injection. Compounded PT-141 is not FDA-approved, and the FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed (Compounding and the FDA: Questions and Answers).
Who PT-141 is for, and what "off-label" means here
According to MedlinePlus, the approved bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD), a low sexual desire that causes distress, in women who have not gone through menopause, who haven't had low desire in the past, and whose low desire isn't caused by a medical or mental health problem, a relationship problem, or a medication. MedlinePlus also says it shouldn't be used for HSDD after menopause, in men, or to improve sexual performance.
That label matters for two reasons:
- Other uses are off-label. CAPO Health's providers may prescribe compounded PT-141 for women and for men when they decide it's safe and appropriate. Any use outside the approved label is off-label: a medical decision, made with you, about a use with less evidence behind it. Individual results vary.
- Causes come first. Low desire has many possible causes, including stress, relationships, medicines and health conditions. That's why your provider asks about all of them before prescribing anything.
Where to get PT-141 prescribed by a licensed provider
A telehealth visit is a real medical evaluation, done remotely. At CAPO Health it works like this:
- Choose your questionnaire. There are separate secure intakes for women and for men, because the health questions differ. It takes about ten minutes.
- A licensed provider reviews it. Medical care is provided by the licensed providers of Arora Health & Aesthetics, LLC, led by Dr. Sean Arora, MD. Your provider is licensed in the state where you're located at the time of your visit, and pays particular attention to your blood pressure, heart history and medicines.
- The provider decides. If PT-141 is appropriate, you get a prescription with clear instructions. If it isn't, you're notified and nothing is dispensed; our Refund Policy explains the refund.
- A licensed pharmacy prepares and ships it, and follow-up continues online. Questions and side effects go to your provider through the patient portal.
Whichever service you use, you can check the prescriber yourself. A National Provider Identifier (NPI) is a unique 10-digit number for health care providers, as CMS explains, and anyone can search it in the public NPI Registry. Our medical group is led by Dr. Sean Arora, MD, NPI 1841729449. For the pharmacy, the FDA's BeSafeRx program lists the basics: it requires a prescription, is licensed by a state board of pharmacy, has a licensed pharmacist you can ask, and gives a U.S. address and phone number.
Ready when you are. Choose the questionnaire for women or for men; a licensed provider reviews your answers and decides.
See if you qualify →PT-141 injection vs. nasal spray
CAPO Health's providers can prescribe compounded PT-141 in two forms, both used as needed, as your provider directs:
- PT-141 injection. A small injection under the skin. Injection-site reactions can occur.
- PT-141 nasal spray. Needle-free. Nasal irritation can occur.
The MedlinePlus information describes the approved injection. There is no FDA-approved bremelanotide nasal spray: the spray is a compounded preparation, and your provider decides whether it fits you. Use it only as your provider and your pharmacy label direct, and never more often than prescribed.
PT-141 side effects and safety
MedlinePlus lists these for bremelanotide, and the Important Safety Information for PT-141 injection and PT-141 nasal spray covers them too:
- Nausea is the most common side effect, mostly after the first dose, and usually lasts about two hours. Vomiting, headache, flushing, nasal stuffiness, cough, tiredness and dizziness can also occur.
- Blood pressure and heart rate. MedlinePlus notes a temporary increase in blood pressure and decrease in heart rate that may last up to 12 hours after a dose. PT-141 is not for people with high blood pressure that isn't controlled or with heart disease.
- Skin darkening. Bremelanotide can darken areas of the skin, including the face, gums and breasts, and the darkening may not go away after stopping.
- Other medicines. It can slow digestion and affect some medicines taken by mouth, including naltrexone. Tell your provider about every medicine you take, and about pregnancy or pregnancy plans.
Report side effects to your provider. For a medical emergency, call 911.
PT-141 cost
CAPO Health plans are self-pay, and insurance isn't required. Current prices for the injection and the nasal spray are on their treatment pages, and your provider confirms your plan after the review.
Questions to ask before you start PT-141
- Is PT-141 the right tool for my concern? Or is the question really about something else, like blood flow, stress or a medicine I take?
- Is my use off-label, and what does the evidence show? Ask plainly.
- Is my blood pressure where it needs to be? And what should I watch for after a dose?
- Injection or nasal spray, and how often at most?
- What about my other medicines? Including anything I take by mouth every day.
Frequently asked questions
Can I get PT-141 prescribed online?
Yes, through a telehealth visit, if a licensed provider decides it's safe and appropriate for you. At CAPO Health you complete a secure questionnaire for women or for men, a provider licensed in your state reviews it, and a licensed pharmacy ships your medication if it's prescribed. Not everyone qualifies.
Are PT-141 and bremelanotide different medicines?
No. PT-141 is the name bremelanotide had during its development: one active ingredient, two names. Compounded PT-141 is prepared by a state-licensed pharmacy and is not FDA-approved.
Is compounded PT-141 FDA-approved?
No. The FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed. Any use your provider prescribes it for may be off-label.
Can men use PT-141?
The bremelanotide medicine the FDA has approved is labeled only for premenopausal women with HSDD, and MedlinePlus says it shouldn't be used in men. A provider may still prescribe compounded PT-141 to a man off-label, after reviewing his heart history and medicines. Evidence for that use is more limited, and individual results vary.
How is PT-141 different from tadalafil?
Tadalafil is a PDE5 inhibitor that works by increasing blood flow during sexual stimulation. PT-141 acts on melanocortin receptors in the brain, which are involved in desire and arousal. Your provider can help you decide which question you're trying to solve.
See if PT-141 is right for you
Start your online visit in about ten minutes. A licensed provider reviews your answers and decides what's appropriate for you.
See if you qualify → Prescription only if a licensed provider determines it is clinically appropriate. Not everyone qualifies. Individual results vary.Sources
- MedlinePlus, National Library of Medicine. Bremelanotide Injection.
- MedlinePlus, National Library of Medicine. Tadalafil.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
- U.S. Food and Drug Administration. BeSafeRx: Considering an Online Pharmacy?.
- Centers for Medicare & Medicaid Services. National Provider Identifier Standard (NPI).
- Centers for Medicare & Medicaid Services. NPPES NPI Registry.